216 related articles for article (PubMed ID: 7029283)
1. Drug therapy: cerebral vasodilators (first of two parts).
Cook P; James I
N Engl J Med; 1981 Dec; 305(25):1508-13. PubMed ID: 7029283
[No Abstract] [Full Text] [Related]
2. Cerebral vasodilators (second of two parts).
Cook P; James I
N Engl J Med; 1981 Dec; 305(26):1560-4. PubMed ID: 7031468
[No Abstract] [Full Text] [Related]
3. Pharmacology of dementia.
Klawans HL; Genovese N
Neurol Clin; 1986 May; 4(2):459-67. PubMed ID: 2872586
[TBL] [Abstract][Full Text] [Related]
4. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
Prosenz P; Tschabitscher H
Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
[No Abstract] [Full Text] [Related]
5. [Treatment of cerebral vascular insufficiency syndromes in old age. Controlled research by double blind technic].
Mars G; Nebuloni G
G Gerontol; 1970 Mar; 18(3):153-76. PubMed ID: 4919664
[No Abstract] [Full Text] [Related]
6. The effect of cyclandelate on cerebral circulation. A double blind trial with clinical and radiocirculographic investigations.
Eichhorn O
Vasc Dis; 1965 Nov; 2(6):305-15. PubMed ID: 5323511
[No Abstract] [Full Text] [Related]
7. Vasodilators in senile dementias: a review of the literature.
Yesavage JA; Tinklenberg JR; Hollister LE; Berger PA
Arch Gen Psychiatry; 1979 Feb; 36(2):220-3. PubMed ID: 420543
[TBL] [Abstract][Full Text] [Related]
8. [Long-term medical treatment of acute cerebrovascular disease sequelae (comparison papaverine-piribedil].
Piccinelli A; Neri G; Agnoli A
Minerva Med; 1974 Nov; 65(80):4199-213. PubMed ID: 4610451
[No Abstract] [Full Text] [Related]
9. [Cerebral circulatory improvers and metabolic activators].
Otomo E
No To Shinkei; 1994 Mar; 46(3):239-44. PubMed ID: 8192938
[No Abstract] [Full Text] [Related]
10. Drugs for dementia.
Drug Ther Bull; 1975 Oct; 13(22):85-7. PubMed ID: 1102280
[No Abstract] [Full Text] [Related]
11. Vasodilators in senile dementia.
Br Med J; 1979 Sep; 2(6189):511-2. PubMed ID: 497664
[No Abstract] [Full Text] [Related]
12. Testing for cerebrovascular reactivity. A method for estimation of the efficiency of cerebral vasodilating therapy in cerebrovascular disease.
Sterman-Marinchescu C; Georgescu G; Teodorini E
Rev Roum Neurol; 1973; 10(4):325-40. PubMed ID: 4588383
[No Abstract] [Full Text] [Related]
13. [Results of the use of Dilpavan in neurosurgery].
Christiaens JL; Dadsetan T
Lille Med; 1972; 17():Suppl 5:1063-5. PubMed ID: 4639554
[No Abstract] [Full Text] [Related]
14. [Effects of vasodilators on the cerebral circulation].
Miyazaki M
Naika; 1967 Jan; 19(1):141-5. PubMed ID: 6060632
[No Abstract] [Full Text] [Related]
15. Cerebral vasodilators.
Br Med J; 1971 Jun; 2(5763):702-3. PubMed ID: 4933650
[No Abstract] [Full Text] [Related]
16. Effect of papaverine on regional blood flow in focal vascular disease of the brain.
McHenry LC; Jaffe ME; Kawamura J; Goldberg HI
N Engl J Med; 1970 May; 282(21):1167-70. PubMed ID: 4909323
[No Abstract] [Full Text] [Related]
17. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
Probst G; Keiser G
Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
[No Abstract] [Full Text] [Related]
18. [Comparative effect of cyclandelate and papaverine on the cerebral circulation of the rabbit].
Dumery JP
Nouv Presse Med; 1976 Oct; 5(32):2081. PubMed ID: 980735
[No Abstract] [Full Text] [Related]
19. The effect of vinpocetine on cerebral blood flow in patients with cerebrovascular disorders.
Tamaki N; Kusunoki T; Matsumoto S
Ther Hung; 1985; 33(1):13-21. PubMed ID: 3841996
[No Abstract] [Full Text] [Related]
20. Effect of proxazole on total and regional cerebral blood flow.
Heiss WD; Prosenz P; Bruck J
Arzneimittelforschung; 1973 Jun; 23(6):772-5. PubMed ID: 4579949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
